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ChromatographyAbstract Large-scale production of insulin still represents the key step in helping diabetic patients
throughout the world. Many species and approaches have been used for the production of insulin.
In this study, we puriﬁed and characterized for the ﬁrst time pancreatic insulin from the Arabian
camel (Camelus dromedarius) using a modiﬁed acid-alcohol extraction method. After extraction
insulin was puriﬁed using a one-step gel ﬁltration on a Sephadex G-50 column leading to a puriﬁ-
cation yield of 80 mg/kg (20%) of camel pancreas. The purity of camel insulin was assessed by
SDS–PAGE and HPLC using insulin from human, bovine and porcine as standards. Molecular
weight was determined for puriﬁed camel insulin as 5800 Daltons and its amino acid composition
is similar to that known for other species. The functional characterization of puriﬁed crude camel
insulin was demonstrated in vitro by positive competition by radioimmunoassay and in vivo showing
camel insulin inducing acute hypoglycaemia in mice. Together, our study reports for the ﬁrst time
the successful puriﬁcation of functional insulin from camel pancreas with similar properties com-
pared to other insulin species. This is of great interest given that the camel represents considerable
economic worth in many countries.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Insulin is one of the important pancreatic homoeostasis
involved in glucose homeostasis. Therefore, any dysfunction
in the organism to produce and/or respond to insulin is known
to cause Diabetes. Indeed, type 1-diabetes is characterized by a
long-term process of autoimmune reactions leading to the
destruction of insulin-producing islets of Langerhans in the
human pancreas. Consequently, the production of insulin in
response to an increase of glucose in the blood is critically
Puriﬁcation of camel insulin 575compromised and the endocrine control of the plasma glucose
levels is dramatically deregulated causing type 1-diabetes. This
situation is of course fatal unless the diabetic patient is supple-
mented by exogenous insulin. Insulin used as anti-diabetic
therapy is principally extracted from bovine and porcine
pancreata.
The presence of the insulin gene in camels has been recently
investigated and the entire gene has been successfully cloned
and the related protein was characterized in the Escherichia
coli expression system (Al-Swailem et al, 2008). The chemical
structure of insulin puriﬁed from various mammals was deter-
mined (Smith, 1964) including the native camel insulin which
was crystallized and characterized in 1972 (Danho, 1972).
There are many different methods for the extraction of
insulin from the pancreas of many animals. Most of the earli-
est methods were based on acid–ethanol extraction followed by
gel ﬁltration and crystallization (Smith, 1964; Danho, 1972;
Epstein and Anﬁnsen, 1963; Shapcott and O’Brien, 1970;
Baragob et al., 2011). Indeed, the homogenization of the pan-
creas was performed using ethanol acidiﬁed with various acids
such as hydrochloric (HCl), sulphuric (H2SO4), and phospho-
ric (H3PO4) acids. The utilization of acid ethanol for insulin
extraction protects against enzymatic degradation since under
such conditions insulin is known to be highly soluble whereas
the proteolytic enzymes and other contaminant proteins
present a very low solubilization. After the separation of the
supernatant containing proteins from the solid tissue and deb-
ris by centrifugation, the soluble proteins can be neutralized
using either ammonium hydroxide (NH4OH), calcium carbon-
ate (CaCO3) or calcium sulphate (CaSO4). The next steps of
extraction can be carried out through evaporation of ethanol
or precipitation of the extract with ammonium acetate allow-
ing the solubilization of fatty substances and precipitation of
proteins. After defatting of the extract the crude insulin can
be obtained by the addition of high concentrations of salts
(NaCl) which allow insulin to be separated from non-protein
compounds as well as some contaminating proteins and poly-
peptides. The crude insulin can be further puriﬁed by repeated
crystallization and ﬁltration as recently reported for the puriﬁ-
cation of pancreatic camel insulin but the extraction yield was
still very low (Baragob et al., 2011). In addition, the puriﬁca-
tion steps may also consist of various chromatographic tech-
niques including gel ﬁltration, ion-exchange system and high
performance liquid chromatography (HPLC). However, some
methods limited the extraction protocol after removal of solid
tissue to direct puriﬁcation by ion exchange chromatography
followed by several steps of HPLC.
In this study, we successfully puriﬁed insulin from camel
pancreas using two different methods of extraction followed
by gel ﬁltration chromatography, ion exchange and/or high
performance liquid chromatography. Moreover, we function-
ally characterized puriﬁed camel insulin both in vitro using
radioimmunoassay and in vivo for its ability to reduce the
blood glucose levels in mice.
2. Material and methods
2.1. Chemicals and reagents
Recombinant human insulin expressed in E. coli, and insulin
from bovine and porcine pancreas, were purchased from theSigma Chemical Company (St. Louis, Missouri, USA).
Calibration proteins for SDS–PAGE were from Boehringer
Mannheim (Germany). Sephadex G-50, acrylamide, N-N-
methylene bis-acrylamide, SDS, ampholine, standard pI mark-
ers, and Commassie blue-R250 were from Pharmacia Biotech
(Sweden). All other chemicals were of analytical grade.
2.2. Extraction of crude camel insulin
Pancreata of young camels (Camelus dromedarius) were
obtained from the central slaughterhouse in Riyadh, frozen
in situ with liquid nitrogen. Organs were dissected free from
adherent fat and connective tissues, cut into small pieces and
homogenized in 80% ethanol/water solution acidiﬁed with
orthophosphoric acid containing 0.5 mM phenylmethanesulfo-
nyl ﬂuoride (PMSF). Extraction and ethanol evaporation
methods using either a Rotary evaporator (Bibby, UK) (meth-
od 1) or cold absolute ethanol and diethyl ether (method 2) are
described in Fig. 1 and Fig. 2, respectively.
2.3. Gel ﬁltration chromatography
Crude camel insulin prepared by Method 1, was dissolved in
10 ml of 1 M acetic acid and loaded onto a Sephadex G-50
(2.5 · 90 cm) column. Equilibrations of the column and insulin
elution were performed with 30% acetic acid containing
0.15 M NaCl at 4 C. Chromatography was performed at
0.5 ml/min, collecting 3 ml fractions by an FPLC AKTA Puri-
ﬁer (GE Healthcare). Camel insulin was identiﬁed by passing
bovine insulin standard through the column under similar con-
ditions. Fractions containing insulin-like immunoreactivity
were pooled and lyophilized (FTS Systems Stone Ridge, USA).
2.4. Ion exchange chromatography
The lyophilized insulin containing material was redissolved in
a buffer composed of 0.06 M Tris–HCl (pH 8.4), 0.08 M and
60% (v/v) ethanol and applied onto a QAE-Sephadex A-25
(2.5 · 10 cm) column (Pharmacia, Uppsala) equilibrated in
the same buffer. The adsorbed material was eluted with
0.08 M NaCl and monitored by absorbance at 280 nm
(Fig. 4). The unique insulin containing peak was pooled,
lyophilized and then desalted on 1.2 · 47 cm column of Sepha-
dex G-50 (superﬁne) at 4 C.
2.5. High performance liquid chromatography (HPLC)
HPLC was carried out using Varian 5000 LC (Varian, USA)
equipped with a variable wavelength detector set at 280 nm.
The estimation of the purity was examined on a
7.8 · 300 mm Waters Insulin HMWP SEC column equili-
brated with 0.1% Arginine/Acetonitrile/Acetic acid (65: 20:
15). The insulin standards (human, bovine, porcine) and the
test samples (camel insulin, peak containing insulin from gel
ﬁltration and ion exchange chromatography steps) were
prepared by dissolving them to 4 mg/ml in the mobile phase
solutions. The chromatographic analysis was carried out at
room temperature at a ﬂow rate of 1 ml/min using the injected
volume of 100 ll and repetitive injections of insulin standard
to equilibrate the columns.
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Figure 1 Detailed method 1 for the extraction and puriﬁcation of crude camel insulin.
576 B.A. Elamin et al.2.6. SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
SDS–PAGE in discontinuous slab gels was performed to pro-
vide a good resolution of separated peptides. For this, high gel
buffer concentration (1 M Tris) and 6% cross-linking, pH 8.45
were used in both stacking (4%) and resolving (16%) gels.
Also, glycine was replaced by tricine in the cathodal buffer
which has signiﬁcantly improved the destacking of the
peptides. Bovine insulin and low molecular weight protein
markers (Trypsin inhibitor, Cytochrome C, Aprotinin, and
insulin chain B) were used as standards for characterization
of camel insulin molecular size. Electrophoresis was conducted
at 20 V for 4 h at 10 C. The gel was then ﬁxed with 50%
methanol and 10% acetic acid before its staining using 0.4%
Commassie blue R-250. The molecular weights of camel and
bovine insulin were determined by plotting a standard curve
using the relative mobility of molecular weight markers.
2.7. Determination of the isoelectric point
Isoelectric point of the protein sample was determined by
immobilized pH gradient (IPG) isoelectric focusing–polyacryl-
amide gel electrophoresis (IEF–PAGE). The gel was made
with 40% ampholine at a pH range from 3.5% to 10.0. Camelinsulin solution containing 10–30 lg and standard pI markers
were focused at constant 5 Watts for 75 min at 10 C. Protein
bands were then ﬁxed in 15% of trichloroacetic acid (TCA)
and stained with coomassie brilliant blue R-250.
2.8. Determination of amino acid composition
Amino acid analysis was performed by HPLC consisting of an
HP 1090 AminoQuant system (Hewlett–Packard) equipped
with a programmable auto-injector capable of performing a
pre-column derivatization. The mobile phase (solvent A) was
12.5 mM sodium acetate, 72 mM triethylamine (TEA), and
10 lM ethylene-diamine-tetra-acetic acid, (EDTA) (pH 7.2)
with 25 mM tetrahydrofuran (THF); solvent B: 550 ml metha-
nol, 450 ml acetonitrile and 5% acetic acid). The column
(Hypersil-ODS, 5 lm ID, 200 · 2.1 mm) was operated at
40 C and eluted by a two-step gradient from 0% to 5% of
solvent B over 6 min, then increased to 37% at 22 min, at a
constant ﬂow rate of 0.45 ml/min. The derivatization is fully
automated within one injector sequence consisting of 7 ll of
O-Phthalaldehyde (OPA)/3-mercaptopropionic acid (3-MPA)
and 1.2 ll of sample (amino acids). The detection was per-
formed at excitation and emission wavelengths of 228 nm
and 455 nm, respectively.
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Figure 2 Detailed method 2 for the extraction and puriﬁcation of crude camel insulin.
Puriﬁcation of camel insulin 577Amino acid hydrolysate of pure insulin was obtained by
adding 200 ll of 6 N HCl containing 0.1% of phenol (w/v)
and 0.05% b-mercaptoethanol. After incubation for 22 h at
110 C, HCl was evaporated and the dried samples were dis-
solved in distilled water and aliquoted into injection vials for
HPLC analysis. For the determination of cystine/cysteine
residues, samples were treated with performic acid (200 ll for
2.3 mg) at 4 C for 4 h. For proline determination, the deriv-
atization was carried out with 9-ﬂourenylmethylchloroformate
(FMOC) and sample excitation at 262 nm followed by emis-
sion measurement at 310 nm.
2.9. Radioimmunoassay (RIA)
Samples were subjected to insulin radioimmunoassay using
standard kit (DiaSorin S.r.l; Italy) containing 125I-labelled por-
cine insulin (1.37 lCi), insulin standards and samples, insulin
antiserum, and precipitating reagent according to the manu-
facturer’s instructions. Brieﬂy, samples and reagents were
mixed in 1.5 ml eppendorf tubes in duplicates and incubated
for 90 min at room temperature. Then 1 ml of the precipitating
reagent was added into all tubes except those used to deter-
mine the total activity. After mixing and incubation for
15 min at room temperature, tubes were centrifuged for15 min at 2000g. The supernatants were discarded, the tubes
were dried and the radioactivity of the precipitates was then
measured using 1275 Minigamma Gamma counter (Pharmacia
LKB, Sweden).
2.10. Hypoglycaemic effects
Hypoglycaemic activity was performed according to Akinci
et al. (1998). Experiments were conducted with 30 male
and female white mice weighing 15–20 g. The mice were di-
vided into three groups, A, B and C. The animals were fasted
overnight before subjection to intravenous (tail vein) injec-
tions. The standard group (group A) was injected with
0.5 mg/g body weight of bovine insulin. Mice of group B
were given a similar dose of camel insulin (test group), while
the control group (C) received normal saline only. Blood
samples were drawn from the tails of the treated rats at
30, 60, 120, 240, and 360 min after insulin injection. Instant
blood glucose levels were measured using strips of Accutrend
Alpha Glucometer (Boehringer Mannheim, Germany) and
ﬁve readings of glucose concentration for each group of mice
were taken. The hypoglycaemic effect of insulin is expressed
as the change in blood glucose levels in mg/dl compared to
saline-treated mice.
2.8 
2.4 
2.0 
1.6 
1.2 
0.8
0.4 
0.0
0 20 40 60 80 100 120
Fraction Number
A
bs
or
ba
nc
e 
at
 2
80
 n
m
A B C D 
C       S
A    B     C    D    S 
2.4
2.0
1.6 
1.2 
0.8 
0.4 
0.0 
Fraction Number
A
bs
or
ba
nc
e 
at
 2
80
 n
m
0 20 40 5010 30 60
A 
B C 
D 
2.8 
2.4 
2.0 
1.6 
1.2 
0.8 
0.4 
0.0 
Fraction Number
A
bs
or
ba
nc
e 
at
 2
80
 n
m
0 20 40 5010 30
A B 
C 
Figure 3 Gel ﬁltration and ion-exchange chromatography for camel insulin extraction. (A) Elution proﬁle of crude camel insulin
obtained using method 1 of extraction and a Sephadex G-50 (medium) column (2.5 · 90 cm). The inset panel represents SDS–PAGE
patterns of the peak fractions using 16% acrylamide gel and 20–25 lg of sample loads. Lane C and S correspond to the peak C and bovine
insulin used as standard, respectively. (B) Elution proﬁle of camel insulin containing peak (peak C in panel A) obtained from second gel
ﬁltration using Sephadex G-50 (superﬁne) column (47 · 1.2 cm). The inset panel represents the SDS–PAGE pattern of the resulted peak
shown in panel C using 16% acrylamide gel which represents pure camel insulin. (C) Elution proﬁle of crude camel insulin obtained using
method 2 of extraction and Sephadex G-50 column (1.6 · 94 cm). The inset panel represents the SDS–PAGE patterns of the peak fractions
using 16% acrylamide gel. Lanes are labelled according to the peaks eluted with S corresponding to bovine insulin used as standard.
Accordingly, the peak and lane D correspond to pure camel insulin.
Table 1 The yield of crude camel insulin extracted using the two different methods, 1 and 2.
Extraction
method
Tissue
weight
Crude
insulin
Insulin rich-peak after
1st gel ﬁltration
Insulin rich-peak after
2nd gel ﬁltration
Insulin peak after ion-
exchange chromatography
1 1 Kg 1.2 g 97 mg 72 mg 18 mg (1.5%)*
2 1 Kg 0.4 g 80 mg (20%)* – –
* Recovery % of crude insulin extracted.
578 B.A. Elamin et al.2.11. Statistical analysis
Statistical signiﬁcance was determined by a two-way ANOVA
with Bonferroni post-tests, or unpaired Student’s t test as
appropriate. A p-value <0.05 (\), <0.01 (\\) or <0.001
(\\\) was regarded as statistically signiﬁcant.
3. Results
3.1. Extraction and puriﬁcation of crude camel insulin
Insulin was extracted from camel pancreas by two methods of
extraction (Figs. 1 and 2). Using method 1 of extraction, thepancreatic extract was loaded onto a Sephadex G-50 gel ﬁltra-
tion column that resolved it into four peaks (Fig. 3A). The
peak C containing insulin like activity (lane C) was concen-
trated and subjected to SDS–PAGE in parallel using bovine
insulin as standard (lane S) (Fig. 3A inset). Further puriﬁca-
tion of the camel insulin achieved by a QAE-Sephadex A-25
ion exchange column resulted in a single peak (Fig. 3B) corre-
sponding to pure camel insulin as conﬁrmed by SDS–PAGE
(Fig. 3B inset). However using method 2 of extraction, the
gel ﬁltration column separates the pancreatic extract into four
peaks (A, B, C, and D) (Fig. 3C). Peak fractions were then run
on SDS–PAGE along with bovine insulin (lane S) used as the
standard (Fig. 3C inset). As a result, we found that peak D
showed one band which corresponds to pure camel insulin
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Figure 4 HPLC patterns of the puriﬁed crude camel insulin and insulin standards. (A) The peak containing pure insulin from the camel
insulin mixture obtained after ion-exchange chromatography puriﬁcation is shown in peak D in Fig. 3C. As standards, insulin from
human (B), bovine (C), and porcine (D) was used.
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Figure 5 Determination of the apparent molecular weight and
the isoelectric focusing of crude camel insulin. (A) SDS–PAGE
pattern of crude camel insulin (4) after its ﬁnal puriﬁcation on
QAE-Sephadex A-25 column (2.5 · 10 cm) using a 16% acrylam-
ide gel and various low molecular weight protein standards
including, cytochrome C (12.5 kDa)(1), aprotinin (6.5 kDa)(2),
bovine insulin (5.8 kDa)(3), insulin chain B (3.4 kDa)(5), and
Trypsin inhibitor (20.1 kDa)(6). (B) The linear regression plot of
the molecular weight of standard proteins used in function of their
relative mobility on SDS–PAGE gel (Rf) (the arrow indicates the
molecular weight of puriﬁed crude camel insulin).
Puriﬁcation of camel insulin 579(Fig. 3C inset). Moreover, we estimated the extraction yield
using the two methods as shown in Table 1. Indeed, from
the protein present in 1 kg of camel pancreas 18 mg (1.5%)
and 80 mg (6.7%) of insulin were puriﬁed using methods 1
and 2, respectively, clearly indicating a better puriﬁcation yield
with method 2.
3.2. Structural studies on puriﬁed camel insulin
First, we examined the relative electrophoretic mobility of
camel insulin on SDS–PAGE that is shown in Fig. 4A. When
compared with proteins of known molecular mass puriﬁed ca-
mel insulin shows a molecular mass of 5.8 kDa. In addition,
camel insulin showed identical mobility to bovine insulin indi-
cating identical molecular size (Fig. 4B). Moreover, isoelectric
focusing on polyacrylamide gel electrophoresis (IEF–PAGE)
showed that the isoelectric point of camel insulin was 5.4 (data
not shown).
To conﬁrm the molecular mass and purity of the ﬁnal insu-
lin product, HPLC was performed and revealed a single major
peak corresponding to a 9.1 min retention time (Fig. 5A)
which was in excellent agreement with HPLC proﬁles for insu-
lin standards used in humans, bovine and porcine animals as
indicated in Fig. 5B–D, respectively.
3.3. Amino acid composition of puriﬁed camel insulin
To study the amino acid composition we used a comparative
analysis using equivocal concentrations of bovine insulin and
puriﬁed camel insulin. The results shown in Table 2 indicatesimilarities in amino acid composition except for the presence
of one more alanine residue in camel insulin as compared to
Table 2 Amino acid composition of crude camel insulin compared to bovine insulin.
Amino acids Molecular weight Number of
residues (bovine insulin)
Proposed concentration
in g/g of insulin
Measured concentration
in g/g of insulin
Number of residues
(camel insulin)
Aspartate 133.1 3 0.066 0.062 2.8
Glutamate 147.1 7 0.171 0.173 7.08
Serine 105.1 3 0.052 0.05 2.9
Glycine 75.07 4 0.05 0.049 3.92
Histidine 209.6 2 0.07 0.071 2.03
Threonine 119.1 1 0.02 0.023 1.15
Alanine 89.09 3 0.044 0.055 3.75 (+1)*
Arginine 210.7 1 0.035 0.04 1.14
Tyrosine 181.2 4 0.12 0.11 3.66
Valine 117.1 5 0.097 0.082 4.23 (1)*
Phenyalanine 165.2 3 0.082 0.081 2.96
Isoleucine 131.2 1 0.022 0.016 0.73
Leucine 131.2 6 0.131 0.132 6.04
Lysine 182.6 1 0.03 0.034 1.13
Proline 115.1 1 0.019 0.02 1.05
Cysteine 169.2 6 0.168 0.165 5.9
* Difference compared to bovine insulin.
580 B.A. Elamin et al.the bovine species and the existence of four valine residues in
camel insulin compared to ﬁve in bovine insulin.
3.4. Radioimmunoassay on puriﬁed camel insulin
To further characterize puriﬁed camel insulin, we performed
insulin radioimmunoassay using 125I-labelled porcine insulin
and anti-insulin serum for the peptide-antibody reactivity. As
shown in Fig. 6A, puriﬁed camel insulin speciﬁcally
(p< 0.005) competes for the binding of the insulin antibody
with 125I-labelled porcine insulin in potency (afﬁnity) similar
to human, bovine and porcine insulin.
3.5. Hypoglycaemic activity of puriﬁed camel insulin
Finally and with the aim to further demonstrate the biological
functionality of puriﬁed camel insulin in vivo, we usedA B
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** 
Figure 6 Functional characterization of puriﬁed crude camel insulin
the binding of 125I-labelled porcine insulin to the anti-insulin serum b
(}), and puriﬁed camel insulin (n) using bovine serum albumin (in 10·
was performed in duplicate. (B) Hypoglycaemic activity of puriﬁed crud
on the blood glucose levels after intravenous injection of overnight fast
mice (n) were used as positive and negative controls, respectively. Each
levels. Statistical analyses are indicated as follows: **p< 0.001, ***p<intravenous injection of mice as model. This is to investigate
the ability of camel insulin to stimulate glucose uptake from
blood to the animal tissues. As shown in Fig. 6B, puriﬁed ca-
mel insulin speciﬁcally and signiﬁcantly (p< 0.005) decreased
blood glucose levels in a time-dependent manner similar to
bovine insulin used as a positive control. The hypoglycaemic
action of insulin was observed after 30 min (p< 0.01) of injec-
tion to reach a maximal effect after 1 h post-injection
(p< 0.005) before blood glucose levels returned back to the
normal values.
4. Discussion
In this study we describe the successful puriﬁcation and
functional characterization of insulin extracted from camel
pancreas. For this, two methods were compared as described
and our data clearly indicate that method 2 allows a totalBl
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assay point represents the average of ﬁve readings of blood glucose
0.001, and ns no signiﬁcant.
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chromatography whereas method 1 requires a sequence of 2
steps, gel ﬁltration followed by ion-exchange chromatography,
to obtain pure camel insulin. Indeed, we adapted Danho’s
method using a one-step gel ﬁltration chromatography proto-
col leading to a good extraction yield of 20%. Our results are
in agreement with the previous studies using ion-exchange
chromatography for the puriﬁcation of crap ﬁsh and dogﬁsh
insulin (Makower et al., 1982). The isolate amounting to
18 mg/kg wet weight is comparable to 24 mg/kg obtained by
Danho (Danho, 1972) and still largely higher than what has
been recently reported on camel insulin (0.025%) (Baragob
et al., 2011). The molecular weight of camel insulin was in
excellent agreement with the mass of bovine (5.7 kDa) and
porcine (5.7 kDa) insulin as described by Brange (Brange,
1987) and shown in previous observations using SDS–PAGE
on E. coli expressing the cloned camel insulin gene (Al-
Swailem et al, 2008). The isoelectric point of camel insulin
being 5.4 can be considered to be in a similar range to what
has been determined on human insulin (Shapcott and O’Brien,
1970) and other insulin species (Akinci et al., 1998; Brange and
Langkjaer, 1992). Moreover, in HPLC analysis puriﬁed camel
insulin along with the three insulin standards (human, bovine,
and porcine) were used to show the same retention time
(9.1 min) similar to that described by Pharmeuropa (1996).
Thus, our HPLC data clearly conﬁrm the successful puriﬁca-
tion of camel insulin with high purity and similar chromato-
graphic proﬁles with human, bovine and porcine insulin. We
also attempted to determine the amino acid sequence of
puriﬁed camel insulin and our sequence is in agreement with
Danho’s study reporting that the chain B of camel insulin se-
quence differed from the bovine one in that it contains alanine
instead of the valine residue in position 2 (Danho, 1972). How-
ever, as shown in our functional study such a slight difference
in the peptide sequence does not seem to affect the functional-
ity and the potency of camel insulin. Recently, a study on the
cloned camel insulin gene showed 87.5% homology between
camel and human proinsulins (Al-Swailem et al, 2008). Finally,
we performed a functional characterization of puriﬁed camel
insulin using radioimmunoassay (RIA) and insulin hypogly-
caemic test in vivo. In RIA our data clearly demonstrate a po-
sitive reactivity of puriﬁed camel insulin with an anti-insulin
serum which is consistent with those previously reported
(Shuldiner et al., 1989; Conlon et al., 1998) and nicely demon-
strate the functionality of puriﬁed camel insulin. In addition,
the competition of porcine insulin withpuriﬁed camel insulin
further conﬁrms the similarities between these two insulin spe-
cies. In vivo data nicely demonstrate the hypoglycaemic action
of puriﬁed camel insulin. This ﬁnding is similar to what has
been previously reported in the biological test (Brange and
Langkjaer, 1992; Anderson et al., 2002) demonstrating the
biological functionality of puriﬁed camel insulin with a
comparable potency tocommercialized bovine insulin. To-gether, our study reports for the ﬁrst time the rapid and
successful puriﬁcation of insulin from camel pancreas with a
functional characterization in vitro and in vivo.
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